Erika Porcelli


Chief Executive Officer


As CEO of Regulatory Compliance Associates®️ Inc., the number one focus for Erika Porcelli is customer experience. Coming from a background that has touched all aspects of RCA services, Erika Porcelli values the importance of client relations above all.

In her time with RCA, Erika has developed strategies to increase average project revenue by helping the company attract larger, targeted projects while also nurturing the pipeline with smaller ones, for both new and existing accounts. With her she brings extensive knowledge in marketing programs, analysis and market research, marketing communications, and sales process opportunities including identifying potential projects, proposal development, and project awards.

Erika maintains current relationships and pursues new opportunities with her expanding connections to quality, regulatory, and research & development management throughout the life science industry. She provides support to all organizational sizes from small startups to multinational corporations.

Energetic and results-oriented, Erika was formerly the Senior Director of Business Development for RCA’s northern U.S. territory and, most recently, Vice President of Client relations—before her promotion to CEO. With more than 15 years’ experience in relationship building and key account management, Erika’s other areas of expertise include new business development, contract negotiation and administration, and budget management.

Erika resides in Woodbury, Connecticut and is a frequent visitor to the RCA offices in Pleasant Prairie and Tampa.

 

About RCA

 

pharmaceutical consultantsRegulatory Compliance Associates® (RCA) provides worldwide services to the following industries for resolution of compliance and regulatory challenges:

 

We understand the complexities of running a life science business and possess areas of expertise that include every facet of R&D, operations, regulatory affairs, quality, and manufacturing. We are used to working on the front lines and thriving in the scrutiny of FDA-and globally-regulated companies.

As your partners, we can negotiate the potential minefield of regulatory compliance and private equity due diligence with insight, hindsight, and the clear advantage of our unique expertise and experience.

 

To begin the RCA® scoping process today, please enter your information in the blue form below and click the submit button at the bottom of the webpage. 

News

Parenteral Products Sterilization and Extractables Evaluation to Help Ensure Drug Safety...
Read More

News

Parenteral Products Sterilization and Extractables Evaluation to Help Ensure Drug Safety...
Read More

News

Our website uses cookies to give you the best possible experience.

By continuing to use this site, you agree to the use of cookies.
Continue